Establishment of an Allogeneic, Off-the-Shelf Platform for the Treatment of Solid Tumors
Time: 1:45 pm
day: Conference Day One - Track A - Afternoon
Details:
- Manufacturing of Deltacel, an allogenic, non-engineered, off-the shelf Gamma Delta T -cell therapy
- Combination of Deltacel with low-dose irradiation to improve treatment outcomes
- Interim results from Phase I clinical trial
- Using Deltacel as a platform for the creation of targeted immunotherapies
